22 results
Thumbnail

D1.202 - Small-Spotted Catshark Parvalbumin Sensitization in Fish-Allergic Patients

Thumbnail

D1.203 - Pine Nut Allergy in a Pediatric Patient with Multiple Sensitizations to Tree Nuts and Storage Proteins

Thumbnail

D1.204 - Pea-ling Back the Layers: A Systematic Review of Pea Allergies

Thumbnail

D1.205 - Characterization of a cohort of fish allergic portuguese patients

Thumbnail

D1.206 - A 50-year history of IgE-mediated hypersensitivity reactions to Saccharomyces cerevisiae presenting with respiratory symptoms

Thumbnail

D1.207 - “Do nut know what: What is the current role of the prick test and serum IgE in the diagnosis of walnut allergy?

Thumbnail

D1.208 - Clinical relevance of food allergen families

Thumbnail

D1.209 - Pollen and Food Non-Specific Lipid Transfer Proteins: Clinical Presentations and Sensitization Profiles in a Mediterranean Population

Thumbnail

D1.210 - Effects of Omalizumab on Human Basophils in Children with Cow’s Milk Protein Allergy

Thumbnail

D1.212 - IgE mediated allergic reaction to rice

Thumbnail

D1.213 - Exercise-Induced Anaphylaxis in a 18-Year-Old Woman with Egg Allergy and Potential Bird-Egg Syndrome

Thumbnail

D1.214 - Food Allergy:Even in doubt, Challenge Test

Thumbnail

D1.370 - Clinical outcomes and quality of life improvement in children with moderate-to-severe atopic dermatitis and atopic multimorbidity treated with dupilumab

Thumbnail

D1.362 - Exploratory Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of YH35324, a Long-Acting high-affinity IgETrap-Fc protein, in Patients with Chronic Spontaneous Urticaria Refractory to Omalizumab

Thumbnail

D1.363 - Efficacy and safety of Mepolizumab in treatment of eosinophilic granulomatosis with polyangiitis

Thumbnail

D1.364 - Update on the Observed incidence of Anaphylaxis and Serum Sickness in Patients Receiving Omalizumab in a Canadian Tertiary Allergy/Asthma Clinic

Thumbnail

D1.365 - ZL-1503: A Bispecific Antibody Targeting Inflammatory and Pruritogenic Pathways with a Prolonged Serum Half-life and Sustained Activity in Non-human Primates

Thumbnail

D1.366 - Improvement Over Time in Specific Aspects of Quality of Life in Patients with Chronic Spontaneous Urticaria Treated with Omalizumab

Thumbnail

D1.367 - Dupilumab for refractory pruritus in hematological and non-hematological malignancies – preliminary results

Thumbnail

D1.368 - Anti-interleukin-5 treatment in patients with severe eosinophilic asthma provides consistent symptom control for at least 8 years